Rigel Pharmaceuticals Inc (FRA:RI2)
€ 33.87 -0.66 (-1.91%) Market Cap: 651.15 Mil Enterprise Value: 603.10 Mil PE Ratio: 2.35 PB Ratio: 1.69 GF Score: 24/100

Rigel Pharmaceuticals Inc Annual Shareholders Meeting Transcript

May 18, 2021 / 03:00PM GMT
Release Date Price: €30.49 (+0.76%)
Raul R. Rodriguez
Rigel Pharmaceuticals, Inc. - President, CEO & Director

Good morning. I am Raul Rodriguez, and I am the Chief -- President and Chief Executive Officer and a member of the Board of Directors of Rigel Pharmaceuticals. I am very happy to welcome you to the Rigel Pharmaceuticals 2021 Annual Meeting of Shareholders. As you know, we are hosting today's meeting through a virtual online platform hosted by Broadridge Financial Solutions.

Stockholders who are attending the meeting with a valid 16-digit control number will have the opportunity to submit questions or comments during the Q&A portion of this meeting through the text box located on your screen. We will try to answer questions that -- submitted and that are germane to the proposals and/or of this meeting and if we have time. Please submit your questions now to make sure they are received in a timely manner for our review and response.

The time is now 8:02 a.m. on Tuesday, May 18, 2021, and the polls are open for voting for all matters to be presented. The polls will be closed after voting -- to voting after I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot